Journal article
A multi-site case study of community-clinical linkages for promoting HPV vaccination
Human vaccines & immunotherapeutics, Vol.15(7-8), pp.1599-1606
08/03/2019
DOI: 10.1080/21645515.2019.1616501
PMCID: PMC6746520
PMID: 31158042
Abstract
Human papillomavirus (HPV) vaccination rates in the U.S. are suboptimal, requiring innovative partnerships between community and clinical entities to remedy this issue. A rigorous evaluation of HPV-related community-clinical linkages (CCLs) was conducted to understand their components, processes, and outcomes to increase HPV vaccination. Cancer Prevention and Control Research Network (CPCRN) investigators explored CCLs in their communities employing an iterative, case study approach. Information describing nine CCLs on HPV vaccination was collected from representatives from the community organization and clinical setting. Thematic content analysis was used to analyze and interpret data. Five CCLs included a federally qualified health center as the clinical partner, and five included a non-profit organization as the community partner. Five reflected clinically focused integration wherein engagement occurs in the community but vaccine delivery and follow-up occur in the clinical setting. The main impetus was the need to improve HPV vaccination and a community's strong interest in preventing cancer. Noted critical components were a designated person to support the CCL and funding. Results will guide HPV vaccination promotion, education, and intervention efforts. CCLs provide an opportunity to study the adaption, integration, and enhancement of evidence-based approaches to increase HPV vaccination.
Details
- Title: Subtitle
- A multi-site case study of community-clinical linkages for promoting HPV vaccination
- Creators
- Heather M. Brandt - University of South CarolinaRobin C. Vanderpool - University of KentuckySusan J. Curry - University of IowaPaige Farris - Oregon Health & Science UniversityJason Daniel-Ulloa - University of IowaLaura Seegmiller - University of IowaLindsay R. Stradtman - University of KentuckyThuy Vu - University of WashingtonVictoria Taylor - University of WashingtonMaria Zubizarreta - University of South Carolina
- Resource Type
- Journal article
- Publication Details
- Human vaccines & immunotherapeutics, Vol.15(7-8), pp.1599-1606
- DOI
- 10.1080/21645515.2019.1616501
- PMID
- 31158042
- PMCID
- PMC6746520
- NLM abbreviation
- Hum Vaccin Immunother
- ISSN
- 2164-5515
- eISSN
- 2164-554X
- Publisher
- Taylor & Francis
- Grant note
- U48 DP005013 / Centers for Disease Control and Prevention (10.13039/100000030) U48 DP005000-01S2 / Centers for Disease Control and Prevention (10.13039/100000030) U48 DP005006; PI / Centers for Disease Control and Prevention (10.13039/100000030) U48 DP005021 / Centers for Disease Control and Prevention (10.13039/100000030) U48DP005014-01S2 / Centers for Disease Control and Prevention (10.13039/100000030)
- Language
- English
- Date published
- 08/03/2019
- Academic Unit
- Health Management and Policy; Community and Behavioral Health
- Record Identifier
- 9984363634602771
Metrics
23 Record Views